Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2073 ARTÍCULOS , VIENDO DEL 196 AL 210

A systematic review/meta-analysis of prevalence and incidence rates illustrates systemic underrepresentation of individuals racialized as Asian and/or Asian-American in ADRD research

Zhu Y, Park S, Kolady R, Zha W, Ma Y, Dias A, McGuire K, Hardi A, Lin S, Ismail Z, Adkins-Jackson PB, Trani JF, Babulal GM.

Alzheimers Dement. 2024 Jun;20(6):4315-4330. doi: 10.1002/alz.13820. Epub 2024 May 6.

Overlooked cases of mild cognitive impairment: Implications to early Alzheimer's disease

Mian M, Tahiri J, Eldin R, Altabaa M, Sehar U, Reddy PH.

Ageing Res Rev. 2024 Jul;98:102335. doi: 10.1016/j.arr.2024.102335. Epub 2024 May 12.

The Clinical Aspects of COVID and Alzheimer's Disease: A Round-Up of Where Things Stand and Are Headed

Tavares-Júnior JWL, Ciurleo GCV, Feitosa EAAF, Oriá RB, Braga-Neto P.

J Alzheimers Dis. 2024;99(4):1159-1171. doi: 10.3233/JAD-231368.

The risk of Alzheimer's disease and cognitive impairment characteristics in eight mental disorders: A UK Biobank observational study and Mendelian randomization analysis

Liu Y, Xiao X, Yang Y, Yao R, Yang Q, Zhu Y, Yang X, Zhang S, Shen L, Jiao B.

Alzheimers Dement. 2024 Jul;20(7):4841-4853. doi: 10.1002/alz.14049. Epub 2024 Jun 11.

Predictive models of Alzheimer's disease dementia risk in older adults with mild cognitive impairment: a systematic review and critical appraisal

Wang X, Zhou S, Ye N, Li Y, Zhou P, Chen G, Hu H.

BMC Geriatr. 2024 Jun 19;24(1):531. doi: 10.1186/s12877-024-05044-8.

Improving our understanding of the complex relationship between cancer-related cognitive decline and Alzheimer's disease

Fowler ME, Crowe M.

J Natl Cancer Inst. 2024 Sep 1;116(9):1414-1416. doi: 10.1093/jnci/djae146.

Acquired Risk Factors that Influence Risk for Dementia and Possibly Alzheimer Disease

Novak E, Tochtrop M, Schlagel D, Fuller W.

S D Med. 2024 Feb;77(2):87-90.

Brexpiprazole for Agitation Associated With Dementia Due to Alzheimer's Disease

Lee D, Clark ED, Antonsdottir IM, Porsteinsson AP.

J Am Med Dir Assoc. 2024 Oct;25(10):105173. doi: 10.1016/j.jamda.2024.105173. Epub 2024 Jul 22.

Tea, coffee, and caffeine intake and risk of dementia and Alzheimer's disease: a systematic review and meta-analysis of cohort studies

Li F, Liu X, Jiang B, Li X, Wang Y, Chen X, Su Y, Wang X, Luo J, Chen L, Li J, Lv Q, Xiao J, Wu J, Ma J, Qin P.

Food Funct. 2024 Aug 12;15(16):8330-8344. doi: 10.1039/d4fo01750a.

Incidence and prevalence of Alzheimer's disease in China: a systematic review and meta-analysis

Ji Q, Chen J, Li Y, Tao E, Zhan Y.

Eur J Epidemiol. 2024 Jul;39(7):701-714. doi: 10.1007/s10654-024-01144-2. Epub 2024 Aug 1.

A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce

Okonkwo OC, Rivera Mindt M, Ashford MT, Conti C, Strong J, Raman R, Donohue MC, Nosheny RL, Flenniken D, Miller MJ, Diaz A, Soto AM, Ances BM, Beigi MR, Doraiswamy PM, Duara R, Farlow MR, Grossman HT, Mintzer JE, Reist C, Rogalski EJ, Sabbagh MN, Salloway S, Schneider LS, Shah RC, Petersen RC, Aisen PS, Weiner MW; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Netw Open. 2024 Aug 1;7(8):e2427073. doi: 10.1001/jamanetworkopen.2024.27073.

Blood Pressure, Antihypertensive Use, and Late-Life Alzheimer and Non-Alzheimer Dementia Risk: An Individual Participant Data Meta-Analysis

Lennon MJ, Lipnicki DM, Lam BCP, Crawford JD, Schutte AE, Peters R, Rydberg-Sterner T, Najar J, Skoog I, Riedel-Heller SG, Röhr S, Pabst A, Lobo A, De-la-Cámara C, Lobo E, Lipton RB, Katz MJ, Derby CA, Kim KW, Han JW, Oh DJ, Rolandi E, Davin A, Rossi M, Scarmeas N, Yannakoulia M, Dardiotis T, Hendrie HC, Gao S, Carriere I, Ritchie K, Anstey KJ, Cherbuin N, Xiao S, Yue L, Li W, Guerchet M, Preux PM, Aboyans V, Haan MN, Aiello A, Scazufca M, Sachdev PS; as the Cohort Studies of Memory in an International Consortium (COSMIC) Group.

Neurology. 2024 Sep 10;103(5):e209715. doi: 10.1212/WNL.0000000000209715. Epub 2024 Aug 14.

Comparison of subjective cognitive decline and polygenic risk score in the prediction of all-cause dementia, Alzheimer's disease and vascular dementia

Trares K, Stocker H, Stevenson-Hoare J, Perna L, Holleczek B, Beyreuther K, Schöttker B, Brenner H.

Alzheimers Res Ther. 2024 Aug 19;16(1):188. doi: 10.1186/s13195-024-01559-9.

The Relationship Between Physical Activity and Non-Modifiable Risk Factors on Alzheimer's Disease and Brain Health Markers: A UK Biobank Study

Spencer FSE, Elsworthy RJ, Breen L, Bishop J, Morrissey S, Aldred S.

J Alzheimers Dis. 2024;101(4):1029-1042. doi: 10.3233/JAD-240269.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias